These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37962465)

  • 1. P2Y1R silencing in Astrocytes Protected Neuroinflammation and Cognitive Decline in a Mouse Model of Alzheimer's Disease.
    Luo S; Tamada A; Saikawa Y; Wang Y; Yu Q; Hisatsune T
    Aging Dis; 2024 Aug; 15(4):1969-1988. PubMed ID: 37962465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer's disease.
    Tapella L; Dematteis G; La Vitola P; Leva S; Tonelli E; Raddi M; Delconti M; Dacomo L; La Macchia A; Murari E; Talmon M; Malecka J; Chrostek G; Grilli M; Colombo L; Salmona M; Forloni G; Genazzani AA; Balducci C; Lim D
    Glia; 2024 May; 72(5):899-915. PubMed ID: 38288580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment.
    Qiu S; Palavicini JP; Wang J; Gonzalez NS; He S; Dustin E; Zou C; Ding L; Bhattacharjee A; Van Skike CE; Galvan V; Dupree JL; Han X
    Mol Neurodegener; 2021 Sep; 16(1):64. PubMed ID: 34526055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model.
    Reichenbach N; Delekate A; Breithausen B; Keppler K; Poll S; Schulte T; Peter J; Plescher M; Hansen JN; Blank N; Keller A; Fuhrmann M; Henneberger C; Halle A; Petzold GC
    J Exp Med; 2018 Jun; 215(6):1649-1663. PubMed ID: 29724785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer's disease.
    Kim S; Chun H; Kim Y; Kim Y; Park U; Chu J; Bhalla M; Choi SH; Yousefian-Jazi A; Kim S; Hyeon SJ; Kim S; Kim Y; Ju YH; Lee SE; Lee H; Lee K; Oh SJ; Hwang EM; Lee J; Lee CJ; Ryu H
    Mol Neurodegener; 2024 Jul; 19(1):55. PubMed ID: 39044253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ
    Dias L; Madeira D; Dias R; Tomé ÂR; Cunha RA; Agostinho P
    Cell Mol Life Sci; 2022 Jul; 79(8):457. PubMed ID: 35907034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease.
    Nasiri E; Sankowski R; Dietrich H; Oikonomidi A; Huerta PT; Popp J; Al-Abed Y; Bacher M
    Mol Med; 2020 Apr; 26(1):34. PubMed ID: 32303185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
    Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
    J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcurrent Therapy Mitigates Neuronal Damage and Cognitive Decline in an Alzheimer's Disease Mouse Model: Insights into Mechanisms and Therapeutic Potential.
    Kim EH; Lee WS; Kwon DR
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metallothionein III Decreases the Proliferation of Astrocytes and Enhances Pathological Improvements in a Mouse Model of Alzheimer's Disease.
    Lv J; Wang F; Wang T; Shi Y
    Discov Med; 2024 Jun; 36(185):1221-1230. PubMed ID: 38926108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice.
    Vilella A; Bodria M; Papotti B; Zanotti I; Zimetti F; Remaggi G; Elviri L; Potì F; Ferri N; Lupo MG; Panighel G; Daini E; Vandini E; Zoli M; Giuliani D; Bernini F
    Brain Behav Immun; 2024 Jan; 115():517-534. PubMed ID: 37967665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
    Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
    J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV Ameliorates Cognitive Impairment and Neuroinflammation in an Oligomeric Aβ Induced Alzheimer's Disease Mouse Model via Inhibition of Microglial Activation and NADPH Oxidase Expression.
    Chen F; Yang D; Cheng XY; Yang H; Yang XH; Liu HT; Wang R; Zheng P; Yao Y; Li J
    Biol Pharm Bull; 2021 Nov; 44(11):1688-1696. PubMed ID: 34433707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of ATF-4 Attenuates the Endoplasmic Reticulum Stress-Mediated Neuroinflammation and Cognitive Impairment in Experimentally Induced Alzheimer's Disease Model.
    Goswami P; Akhter J; Mangla A; Suramya S; Jindal G; Ahmad S; Raisuddin S
    Mol Neurobiol; 2024 Aug; 61(8):5071-5082. PubMed ID: 38159199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting blood brain barrier-Remote ischemic conditioning alleviates cognitive impairment in female APP/PS1 rats.
    Ma Y; Sun W; Bai J; Gao F; Ma H; Liu H; Hu J; Xu C; Zhang X; Liu Z; Yuan T; Sun C; Huang Y; Wang R
    CNS Neurosci Ther; 2024 Feb; 30(2):e14613. PubMed ID: 38379185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice.
    Carmo MR; Simões AP; Fonteles AA; Souza CM; Cunha RA; Andrade GM
    Eur J Neurosci; 2014 Feb; 39(4):614-22. PubMed ID: 24304101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5×FAD Mice.
    Mei Z; Liu J; Schroeder JP; Weinshenker D; Duong DM; Seyfried NT; Li Y; Jin P; Wingo AP; Wingo TS
    Mol Neurobiol; 2024 Jun; 61(6):3343-3356. PubMed ID: 37989983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Direct Vascular Contact to Astrocytes in the Hippocampus as an Initial Event in Alzheimer's Disease. Evidence from Patients, In Vivo and In Vitro Experimental Models.
    Pomilio C; Presa J; Oses C; Vinuesa A; Bentivegna M; Gregosa A; Riudavets M; Sevlever G; Galvan V; Levi V; Beauquis J; Saravia F
    Mol Neurobiol; 2024 Aug; 61(8):5142-5160. PubMed ID: 38172288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.